MSK investigators Joan Massagué and Anna Obenauf
In the Lab
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, April 9, 2015

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

CAR T cell immunotherapy
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, March 31, 2015

Cell therapies that use patients’ own immune cells to attack cancer are a promising and rapidly growing area of research.

Exceptional responders of new drugs in clinical trials.
Decoder
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, March 24, 2015

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Pictured: Charles Sawyers
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 12, 2015

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.

Surgeon Larissa Temple
Support
By Maureen Salamon, BA, Freelance Writer  |  Thursday, February 26, 2015

A new online survey aims to provide doctors with real-time information on their patients’ quality of life after rectal surgery.

Peter Scardino, Chair of MSK’s Department of Surgery and a specialist in the treatment of prostate cancers.
Q&A
By Jim Stallard, MA, Writer/Editor  |  Tuesday, February 24, 2015

Peter Scardino, Chair of MSK’s Department of Surgery, gives his views on what lies ahead for the surgical treatment of cancer.

Oren Cahlon and Nancy Lee
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Tuesday, February 17, 2015

Proton therapy uses charged particles to target tumors with precision while reducing the risk of treatment-related side effects.

Epigenetics
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, January 30, 2015

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, January 28, 2015

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Pictured: José Baselga
Video
By Memorial Sloan Kettering  |  Thursday, January 15, 2015

MSK Physician-in-Chief José Baselga discusses the amazing progress that has been made in fighting cancer.

Sandra D’Angelo and Jedd Wolchok
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Tuesday, January 6, 2015

A new treatment for advanced melanoma is the latest promising advance in immunotherapy tested in large part by our scientists.

Pictured: Peter Kingham
Perspective
By Peter Kingham, MD, Surgical Oncologist  |  Monday, December 15, 2014

Our top cancer specialists come together to consult on complex cases at weekly Disease Management Team meetings.

Pictured: Eytan Stein
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 11, 2014

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

Pathologists at MSK
Feature
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, December 4, 2014

The most effective cancer treatment starts with an accurate diagnosis. Pathologist Meera Hameed explains the pathologist’s crucial contributions.

Pictured: William Alago
Q&A
By Maureen Salamon, BA, Freelance Writer  |  Monday, November 24, 2014

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Center News

Stay Informed

Get the latest information about cancer care and research every month.